Does an aspirin a day keep the doctor away? Is alcohol good or bad for your cardiac health? In this week’s episode, Dr. Alain Bouchard and Dr. Martha Gulati delve into everything you ever wanted to know about primary prevention with this week's focus: Aspirin

Featuring: 
Michael Gibson M.S., M.D. - Chief Executive Officer, Baim Institute for Clinical Research
Kenneth Mahaffey M.D. - Professor - Stanford, Medicine - Cardiovascular Medicine

Does an aspirin a day keep the doctor away? Is alcohol good or bad for your cardiac health? In this week’s episode, Dr. Alain Bouchard and Dr. Martha Gulati delve into everything you ever wanted to know about primary prevention with this week's focus: Prevention

Dr. Bouchard discusses " Familial Hypercholesterolemia" with Dr. Pradeep Natarajan from Harvard.

Arts in Health can involve artists trained to implement art to promote healing in healthcare and community settings. 

Dr. Bouchard discusses " Hypertension" with Dr. Suzanne Oparil, M.D. Distinguished Professor of Medicine. Professor of Cell, Developmental and Integrative Biology. Director, Vascular Biology and Hypertension Program. Section Chief of Vascular Biology and Hypertension.

Hypertension is a pervasive problem and affects nearly 50% of the US population including over 90 million adults with uncontrolled hypertension and an estimated 34 million untreated. For an adult 40 years of age without high blood pressure, the lifetime risk of developing hypertension is 93% for African Americans, 92% for Hispanics, 86% for whites, and 84% for Chinese adults.

Dr. Bouchard discusses " THE HDL CHOLESTEROL CONUNDRUM" with Dr. John J.P. Kastelein, M.D., Ph.D., FESC, Professor of Medicine, University of Amsterdam.

The role of High-density lipoprotein (HDL) cholesterol in the development of atherosclerosis and cardiovascular (CV) morbidity and mortality has long been recognized.

Dr. Bouchard discusses " NON-STATIN THERAPIES FOR LDL CHOLESTEROL LOWERING" with Dr. John J.P. Kastelein, M.D., Ph.D., FESC, Professor of Medicine, University of Amsterdam.

The role of statin in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD) has been well demonstrated to lower major cardiovascular events.

Dr. Bouchard discusses "LIPOPROTEIN (a), A BIOMARKER FOR STROKE" with Dr. Leslie Cho, Director of the Cleveland Clinic's Women's Cardiovascular Center.

Cardiovascular disease remains the leading cause of death and disability worldwide.

Despite advances in lipid management, there remain significant risks of heart disease and stroke in patients treated with current therapies such as statin. 

Dr. Bouchard discusses "Regards" in the stroke belt with Dr. George Howard at the University of Alabama at Birmingham.

"REGARDS” is an abbreviation for Reasons for Geographic And Racial Difference in Stroke. It is an observational study of risk factors for stroke in adults 45 years or older. It is co-sponsored by the National Institute of Neurological Disorders and Stroke and the National Institute on Aging.